Skip to main content
Figure 5 | Arthritis Research & Therapy

Figure 5

From: Extracellular nicotinamide phosphoribosyltransferase (NAMPT/visfatin) inhibits insulin-like growth factor-1 signaling and proteoglycan synthesis in human articular chondrocytes

Figure 5

Model for inhibitory effect of extracellular nicotinamide phosphoribosyltransferase on insulin-like growth factor-1 function in chondrocytes. In this hypothetical model, sustained activation of extracellular signal-regulated kinases (ERK) by extracellular nicotinamide phosphoribosyltransferase (eNAMPT) promotes increased phosphorylation of insulin receptor substrate-1 (IRS-1) (serine-312), which negatively regulates the downstream insulin-like growth factor-1 (IGF-1) signaling pathway and thereby matrix synthesis. IGF-1R, insulin-like growth factor-1 receptor.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us